Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xisheng Leng

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Zhonghua Yi Xue Za Zhi|March 19, 2003
[General surgery]Xisheng Leng
Zhonghua Yi Xue Za Zhi|April 16, 2002
[Interleukin-10 inhibits the activation of cultured rat hepatic stellate cells induced by Kupffer cells]Shangeng Weng, Xisheng Leng, Yuhua Wei
Journal of Cancer Research and Clinical Oncology|September 28, 2018
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantationXinyu Li, Lei Huang, Xisheng Leng
Protein and Peptide Letters|May 16, 2009
SELDI protein chip technology for the detection of serum biomarkers for liver diseaseLei Chen, Sarwat Fatima, Jirun Peng, et al.
BMC Surgery|December 14, 2018
Effects of retrograde reperfusion on the intraoperative internal environment and hemodynamics in classic orthotopic liver transplantationChongwei Yang, Lei Huang, Xinyu Li, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 18, 2014
3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells : in vitro and in vivo findingsLei Gong, Yuhua Wei, Xin Yu, et al.
Biochemical and Biophysical Research Communications|February 7, 2018
MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinomaWeihua Zhu, Yazhou Wang, Dafang Zhang, et al.
Hepato-Gastroenterology|April 29, 2015
Outcome after pancreaticoduodenectomy for malignancy in elderly patientsDafang Zhang, Jie Gao, Shu Li, et al.
Pathology Oncology Research : POR|September 13, 2011
Hexokinase II in CD133+ and CD133- hepatoma BEL-7402 CellsLei Gong, Zhuqingqing Cui, Xin Yu, et al.
Chinese Medical Journal|July 22, 2014
Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejectionTao Li, Rui Ma, Jiye Zhu, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Zhonghua Yi Xue Za Zhi|March 19, 2003
[General surgery]Xisheng Leng
Zhonghua Yi Xue Za Zhi|April 16, 2002
[Interleukin-10 inhibits the activation of cultured rat hepatic stellate cells induced by Kupffer cells]Shangeng Weng, Xisheng Leng, Yuhua Wei
Journal of Cancer Research and Clinical Oncology|September 28, 2018
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantationXinyu Li, Lei Huang, Xisheng Leng
Protein and Peptide Letters|May 16, 2009
SELDI protein chip technology for the detection of serum biomarkers for liver diseaseLei Chen, Sarwat Fatima, Jirun Peng, et al.
BMC Surgery|December 14, 2018
Effects of retrograde reperfusion on the intraoperative internal environment and hemodynamics in classic orthotopic liver transplantationChongwei Yang, Lei Huang, Xinyu Li, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 18, 2014
3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells : in vitro and in vivo findingsLei Gong, Yuhua Wei, Xin Yu, et al.
Biochemical and Biophysical Research Communications|February 7, 2018
MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinomaWeihua Zhu, Yazhou Wang, Dafang Zhang, et al.
Hepato-Gastroenterology|April 29, 2015
Outcome after pancreaticoduodenectomy for malignancy in elderly patientsDafang Zhang, Jie Gao, Shu Li, et al.
Pathology Oncology Research : POR|September 13, 2011
Hexokinase II in CD133+ and CD133- hepatoma BEL-7402 CellsLei Gong, Zhuqingqing Cui, Xin Yu, et al.
Chinese Medical Journal|July 22, 2014
Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejectionTao Li, Rui Ma, Jiye Zhu, et al.
Pageof 3